Sarah Lastakchi

Dr. Sarah Lastakchi

University of Birmingham

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 February 2020 in Genes
Verified
Journal Article
Open access
PDF file
AGAnne-Marie Garrett
Anne-Marie Garrett
Sarah LastakchiSarah Lastakchi
Sarah Lastakchi
Christopher McConvilleChristopher McConville
Christopher McConville
The molecular heterogeneity of glioblastoma has been linked to differences in survival and treatment response, while the development of personalised treatments may be a novel way of combatting this disease. Here we show for the first time that low passage number cells derived from primary tumours are greater than an 86% match genetically to the tumour tissue. We used these cells to identify eight genes that could be used for the personalisation of glioblastoma treatment and discovered a number of personalised drug combinations that were significantly more effective at killing glioblastoma cells and reducing recurrence than the individual drugs as well as the control and non-personalised combinations. This pilot study demonstrates for the first time that whole exome sequencing has the potential be used to improve the treatment of glioblastoma patients by personalising treatment. This novel approach could potentially offer a new avenue for treatment for this terrible disease.

1 January 2020
Verified
Book Chapter
Closed access
Ian MajorIan Major
Ian Major
Sarah LastakchiSarah Lastakchi
Sarah Lastakchi
MDMaurice Dalton
Maurice Dalton
CMChristopher McConville
Christopher McConville

1 January 2020
Verified
Book Chapter
Closed access
DADalia H. Abdelkader
Dalia H. Abdelkader
RARand Ahmad
Rand Ahmad
SASamaneh Alaei
Samaneh Alaei
CGCarol Ann Greene
Carol Ann Greene
NBNiloofar Babanejad
Niloofar Babanejad
GZGhada Zidan
Ghada Zidan